Literature DB >> 23743189

TRAF2 regulates the cytoplasmic/nuclear distribution of TRAF4 and its biological function in breast cancer cells.

Xiaoli Zhang1, Zhifeng Wen, Limei Sun, Jian Wang, Min Song, Enhua Wang, Xiaoyi Mi.   

Abstract

Although numerous studies have shown that tumor necrosis factor receptor-associated factor 4 (TRAF4) plays an important role in the carcinogenesis of many tumor types, its exact molecular mechanism remains elusive. In this study, we examined the regulation function of TRAF2 to the cytoplasmic/nuclear distribution of TRAF4 in the breast cancer cell line. Using cell immunofluorescent staining, we found that TRAF2 and TRAF4 were co-localized to the cytoplasm in MCF-7 cells. Co-immunoprecipitation showed that TRAF2 could interact with TRAF4 in MCF-10A, MCF-7 and MDA-MB-231 cell lines. Western blotting showed TRAF2 depletion by targeted siRNA in MDA-MB-231 cells led to reduced TRAF4 expression in the cytoplasm and augmented TRAF4 expression in the nucleus. Cytoplasmic expression of TRAF4 was augmented and nuclear expression was reduced when MCF-7 cells were transfected with hTRAF2pLPCX-HA-Flag/P874. MCF-7 cells expressing hTRAF2pLPCX-HA-Flag/P874 had enhanced cell proliferation rates. The nuclear expression of NF-κB significantly increased after TNF-α treatment. When hTRAF2pLPCX-HA-Flag/P874 and the siRNA-TRAF4 plasmid were cotransfected, the nuclear expression of NF-κB was significantly reduced compared with cells transfected with hTRAF2pLPCX-HA-Flag/P874 only. In conclusion, TRAF2 appears to interact with TRAF4 and affect the localization of TRAF4 in breast cancer cell lines. The overexpression of TRAF2 augmented the cytoplasmic expression of TRAF4 which promoted cell proliferation and inhibited cell apoptosis by activating NF-κB nuclear transcription. TRAF4 may play an important role in the activation of NF-κB via TRAF2.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743189     DOI: 10.1016/j.bbrc.2013.05.107

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.

Authors:  Juan Zhang; Wei-Jie Dai; Xiao-Zhong Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells.

Authors:  Archita Das; Varadarajan Sudhahar; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

3.  Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression.

Authors:  Fan Yang; Jian Wang; Hua-Yan Ren; Juan Jin; Ai-Lian Wang; Li-Li Sun; Ke-Xin Diao; En-Hua Wang; Xiao-Yi Mi
Journal:  Tumour Biol       Date:  2015-02-24

4.  Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.

Authors:  Hua-Yan Ren; Jian Wang; Fan Yang; Xiao-Li Zhang; Ai-Lian Wang; Li-Li Sun; Ke-Xin Diao; En-Hua Wang; Xiao-Yi Mi
Journal:  Oncotarget       Date:  2015-02-28

5.  TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis.

Authors:  Prabha Peramuhendige; Silvia Marino; Ryan T Bishop; Daniëlle de Ridder; Asim Khogeer; Isabella Baldini; Mattia Capulli; Nadia Rucci; Aymen I Idris
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

6.  Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.

Authors:  Qingde Wa; Changye Zou; Zhuoyuan Lin; Sheng Huang; Xinsheng Peng; Chunxiao Yang; Dong Ren; Dongchu Xu; Yuanqing Guo; Zhuangwen Liao; Bin Wang; Hailan Hu; Shuai Huang; Peiheng He
Journal:  Mol Ther Oncolytics       Date:  2020-04-07       Impact factor: 7.200

7.  Grouper TRAF4, a Novel, CP-Interacting Protein That Promotes Red-Spotted Grouper Nervous Necrosis Virus Replication.

Authors:  Siting Wu; Mengshi Sun; Xin Zhang; Jiaming Liao; Mengke Liu; Qiwei Qin; Jingguang Wei
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.

Authors:  Jiabei Liang; Jian Zhang; Jun Ruan; Yuanyuan Mi; Qiang Hu; Zhirong Wang; Bingbing Wei
Journal:  Med Sci Monit       Date:  2017-11-19

Review 9.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

10.  miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

Authors:  Sonali Sharma; Gabriela Mladonicka Pavlasova; Vaclav Seda; Katerina Amruz Cerna; Eva Vojackova; Daniel Filip; Laura Ondrisova; Veronika Sandova; Lenka Kostalova; Pedro F Zeni; Marek Borsky; Jan Oppelt; Kvetoslava Liskova; Leos Kren; Andrea Janikova; Sarka Pospisilova; Stacey M Fernandes; Medhat Shehata; Laura Z Rassenti; Ulrich Jaeger; Michael Doubek; Matthew S Davids; Jennifer R Brown; Jiri Mayer; Thomas J Kipps; Marek Mraz
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.